← Evidence map

ArticleFrontiers in endocrinology2025

Editorial: The impact of GIP/GIPR on metabolic diseases: how the field is evolving.

Kirk Habegger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41163683